1-5 of 5
Saar I. Gill, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CRISPR-Cas9 Knock out of CD5 Enhances the Anti-Tumor Activity of Chimeric Antigen Receptor T Cells

Inkook Chun, MS, Ki Hyun Kim, PhD, Yi-Hao Chiang, MD, Wei Xie, MD, Yong Gu Gu Lee, PhD, Raymone Pajarillo, MS, Antonia Rotolo, MD PhD, Olga Shestova, PhD, Seok Jae Hong, MS, Mohamed Abdel-Mohsen, PhD, Maria Wysocka, PhD, Hatcher J. Ballard, BS, David M. Barrett, Avery D. Posey, PhD, Daniel Powell, Jr., PhD, Saar I. Gill, MDPhD, Stephen J. Schuster, MD, Stefan K. Barta, MDMRCP,MS, Alain H Rook, MD, Carl H June, MD, Marco Ruella, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 51–52.
https://doi.org/10.1182/blood-2020-136860
Published: 2020
Journal Articles

Clinical Outcomes of Venetoclax Therapy in Patients with Relapsed/Refractory (r/r) Non Hodgkin Lymphomas (NHL)

Mitchell E. Hughes, PharmD, Daniel J. Landsburg, MD, Daniel J Rubin, PharmD, Stephen J. Schuster, MD, Jakub Svoboda, MD, Donald Edward Tsai, MD PhD, Kyle Robinson, MD, Saar I. Gill, MDPhD, Anthony R. Mato, MDMSCE, James Nathan Gerson, MD, Danielle Land, CRNP, Brenda Shelly, CRNP, Alicia McLeish, CRNP, Allison Rago, CRNP, Jennifer Gill, CRNP, Kristy Walsh, BS, Tanya Latorre, RN, Jessica K. Altman, MD, Colleen Timlin, PharmD, Donna Capozzi, PharmD, BCOP, Sunita Dwivedy Nasta, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1706.
https://doi.org/10.1182/blood-2018-99-111194
Published: 2018
Journal Articles

CAR T Cell Cytotoxicity Is Dependent on Death Receptor-Driven Apoptosis

Nathan Singh, MD, Olga Shestova, PhD, Katharina Hayer, Albert Hong, Pranali Ravikumar, MS, Atushi Hoshino, MD PhD, Ophir Shalem, PhD, Matthew D. Weitzman, PhD, Carl H June, MD, Saar I. Gill, MDPhD, Marco Ruella, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 698.
https://doi.org/10.1182/blood-2018-99-117328
Published: 2018
Journal Articles

Prospective Clinical Trial of Anti-CD19 CAR T Cells in Combination with Ibrutinib for the Treatment of Chronic Lymphocytic Leukemia Shows a High Response Rate

Saar I. Gill, MDPhD, Vanessa Vides, BS, Noelle V. Frey, MD, Susan Metzger, BSN, Megan O'Brien, Elizabeth Hexner, MD, Anthony R. Mato, MDMSCE, Simon F Lacey, PhD BS, J. Joseph Melenhorst, PhD, Edward Pequignot, MSc, Whitney Lynn Gladney, PhD, Wei-Ting Hwang, PhD, Anne Lamontagne, Megan Davis, PhD, John C. Byrd, MD, Stephen J. Schuster, MD, Don L. Siegel, MD PhD, Randi E. Isaacs, MD, Carl H June, MD, David L. Porter, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 298.
https://doi.org/10.1182/blood-2018-99-115418
Published: 2018
Journal Articles

Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy

Farhad Ravandi, MD, Camille N Abboud, MD, Luke Paul Akard, MD, Saar I. Gill, MDPhD, Jack W. Hsu, MD, Suman Kambhampati, MD, Irum Khan, MBBS, Delong Liu, MD PhD, Wendy Stock, MD, Janice W Brown, MD, Asad Bashey, MD PhD, Gautam Borthakur, MD, Courtney D. DiNardo, MDMSc, H. Kent Holland, MD, Tapan M. Kadia, MD, Hagop M. Kantarjian, MD, Lawrence E Morris, MD, Scott R Solomon, MD, Richard David Mamelok, MD, Swapna Panuganti, PhD, Rod Van Syoc, Alicia Wong, BS, Deborah Zimmerman, PhD, Melhem Solh, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1407.
https://doi.org/10.1182/blood-2018-99-117231
Published: 2018